|
Skin Diseases, Infectious
|
D012874 |
[Skin diseases caused by bacteria, fungi, parasites, or viruses.
] |
|
1H-indol-3-yl(adamantan-1-yl)methanone
|
C000615718 |
|
|
5-(2-phenyl-3'-indolal)-2-thiohydantoin
|
C418562 |
|
|
Skin Diseases, Metabolic
|
D012875 |
[Diseases of the skin associated with underlying metabolic disorders.
] |
|
TVB-3166
|
C000615719 |
|
|
Skin Diseases, Parasitic
|
D012876 |
[Skin diseases caused by ARTHROPODS; HELMINTHS; or other parasites.
] |
|
Ro 41-3290
|
C418564 |
|
|
Skin Manifestations
|
D012877 |
[Dermatologic disorders attendant upon non-dermatologic disease or injury.
] |
|
shibimijihwang-tang
|
C418565 |
|
|
Skin Neoplasms
|
D012878 |
[Tumors or cancer of the SKIN.
] |
|
enediynol
|
C418566 |
|
|
Skin Physiological Phenomena
|
D012879 |
[The functions of the skin in the human and animal body. It includes the pigmentation of the skin.
] |
|
enediynone
|
C418567 |
|
|
adalinine
|
C418568 |
|
|
Skin Diseases
|
D012871 |
[Diseases involving the DERMIS or EPIDERMIS.
] |
|
Skin Diseases, Vesiculobullous
|
D012872 |
[Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990)
] |
|
purine N1-C6 hydrolase
|
C022480 |
|
|
Skin Diseases, Genetic
|
D012873 |
[Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism.
] |
|
procollagenase
|
C022440 |
|
|
aspergillopepsin II
|
C022442 |
|